Frontlight ResearchEarly access
Trial site
University of Turin, Città della Salute e della Scienza
- 1running trial
Running trials
Active, not recruiting
A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C
Site data: ClinicalTrials.govUpdated 12 Nov 2026